MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0059207
Elite Pharma Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹10.71 Cr
▲ 3% YoY
Net profit · FY 2025
₹1.47 Cr
Net margin 13.7%
EBITDA · FY 2025
₹2.35 Cr
EBITDA margin 21.9%
Authorised capital
₹12 Lakh
Registered with MCA
Paid-up capital
₹11 Lakh
Issued & subscribed
Satisfied charges
₹1.25 Cr
No open charges
Company age
39 yrs
Est. 1987
Employees · EPFO
7
Provident fund records
About Elite Pharma Private Limited
Data last updated:
Elite Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 October 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1987PTC010062. Its GSTIN is 24AAACE4146L1ZQ (Gujarat).
The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹11 Lakh. It is led by directors including Girish Khimji Kantaria and Jatin Popatlal Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1210/11/12 Phase III G.I.D.C. Estate Vatva, Ahmedabad, Gujarat, India – 382445.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.71 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹1.47 Cr (net margin 13.7%) and EBITDA of ₹2.35 Cr (EBITDA margin 21.9%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 3% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹1.25 Cr on record. Court records list 8 cases involving the company, including 1 filed by the company and 6 filed against it.
Elite Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0059207). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elite-pharma.com.
Company Details of Elite Pharma Private Limited
CIN U24231GJ1987PTC010062
Registration Number 010062
Incorporation Date 16 October 1987
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0059207
Key People
Girish Khimji Kantaria Director Jatin Popatlal Patel Director Chintan Hareshbhai Patel Director Recognitions & Rankings of Elite Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address1210/11/12 Phase III G.I.D.C. Estate Vatva, Ahmedabad, Gujarat, India – 382445
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Elite Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Elite Pharma Private Limited
The main business activity of Elite Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Elite Pharma Private Limited FY 2025 filings available
Elite Pharma Private Limited reported revenue of ₹10.71 Cr (up 3% YoY) for FY 2025.
Revenue · FY 2025
₹10.71 Cr ▲ 3%
Net profit · FY 2025
₹1.47 Cr margin 13.7%
EBITDA · FY 2025
₹2.35 Cr margin 21.9%
Compounded Annual Growth Rate (CAGR) of Elite Pharma Private Limited
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 5%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 13%
3 years · compounded
▼ 1%
5 years · compounded
▼ 1%
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 3% growth in the latest year. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Elite Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.35 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.47 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Elite Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 13.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Elite Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Elite Pharma Private Limited
Elite Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Girish Khimji Kantaria | Director | 16 Oct 1987 | 39 Years 0 Months | Current |
| Jatin Popatlal Patel Also directs: Elite Medicare Private Limited | Director | 04 May 2025 | 1 Years 5 Months | Current |
| Chintan Hareshbhai Patel | Director | 28 Apr 2017 | 9 Years 5 Months | Current |
Peer Comparison of Elite Pharma Private Limited
Elite Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Artisan Netcom (India) Private Limited | ₹10.78 Cr (FY 2024) | •••• | •••• | 70.0% | •••• | New Delhi, Delhi, India |
| Triveni Formulations Limited | ₹10.77 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Vijayawada, Andhra Pradesh, India |
| D M Pharma (MKT.) Private Limited | ₹10.76 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Chandigarh, India |
| Oncobiotek Formulations Private Limited | ₹10.73 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Ahmedabad, Gujarat, India |
| Embellish Pharma Tech Private Limited | ₹10.72 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Roorkee, Uttarakhand, India |
| Elite Pharma Private Limited this company | ₹10.71 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Ahmedabad, Gujarat, India |
| Biogenomics Limited | ₹10.7 Cr (FY 2023) | •••• | •••• | 30.0% | •••• | Puducherry, India |
| Arck Life Care Private Limited | ₹10.7 Cr (FY 2025) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Avenza Pharmaceuticals Private Limited | ₹10.69 Cr (FY 2025) | •••• | •••• | 162.0% | •••• | Vadodara, Gujarat, India |
| Medioint Lifescience Private Limited | ₹10.68 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Dhar, Madhya Pradesh, India |
| Ashoka Pharmachem Private Limited | ₹10.66 Cr (FY 2025) | •••• | •••• | 1107.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Elite Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Elite Pharma Private Limited
Elite Pharma Private Limited is audited by RAJ P. SHAH & CO. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAJ P. SHAH & CO. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Elite Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Elite Pharma Private Limited
Open charges
None
Satisfied charges
₹1.25 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jun 2005 | Bank of India | ₹36.97 Lakh | Satisfied |
| 27 Dec 2003 | Bank of India | ₹61.9 Lakh | Satisfied |
| 05 Feb 1996 | Bank of India | ₹2 Lakh | Satisfied |
| 08 Apr 1989 | Bank of India | ₹24 Lakh | Satisfied |
Total charge records: 4 View all charges
Legal Cases of Elite Pharma Private Limited
Elite Pharma Private Limited has 8 court cases on record: 1 filed by Elite Pharma, 6 filed against it, 1 where it is another party. All cases are disposed. Status as checked between 30 Sep 2026 and 05 Oct 2026.
Total cases
8
Filed by the company
1
Filed against the company
6
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 4 | 0 |
| District courts | 2 | 2 | 0 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (S) | Filed against the company by Unichem Laboratories Limited | Disposed |
| High Court of Gujarat | Court case (TAXAP) | Filed against the company by Principal Commissioner | Disposed |
| High Court of Gujarat | Court case (TAXAP) | Filed against the company by Commissioner of Central Excise Ahmedabad I | Disposed |
| District court, SHIVAMOGGA, Karnataka | Criminal miscellaneous application | Filed against the company by State at the Instance of Assistant Druggs Controller | Disposed |
| High Court of Gujarat | Special civil application | Company is another party | Disposed |
Premium access
Full case history
All 8 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Elite Pharma Private Limited
Elite Pharma Private Limited has a workforce of 7 employees as of Mar 03, 2025.
Employee count
7
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Elite Pharma Private Limited
Elite Pharma Private Limited has 6 board changes on record since 1987: 4 appointments and 2 cessations. The latest: Popatlal Harjibhai Patel ceased to be Director on 14 May 2025.
AGM
Elite Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Popatlal Harjibhai Patel ceased to be Director.
Appointed
Jatin Popatlal Patel was appointed as Director.
Filing
Elite Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge registered on 17 Jun 2005 via Charge ID 90112999 with Bank Of India was fully satisfied on 08 Mar 2018.
Charges
A charge registered on 27 Dec 2003 via Charge ID 90112846 with Bank Of India was fully satisfied on 08 Mar 2018.
Charges
A charge registered on 05 Feb 1996 via Charge ID 90109382 with Bank Of India was fully satisfied on 08 Mar 2018.
Charges
A charge registered on 08 Apr 1989 via Charge ID 90108551 with Bank Of India was fully satisfied on 08 Mar 2018.
Appointed
Chintan Hareshbhai Patel was appointed as Director.
Ceased
Haresh Laxmanbhai Patel ceased to be Director.
Charges
A charge with Bank Of India amounted to Rs. 36.97 Lakh with Charge ID 90112999 was registered on 17 Jun 2005.
Charges
A charge with Bank Of India amounted to Rs. 61.90 Lakh with Charge ID 90112846 was registered on 27 Dec 2003.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Elite Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Elite Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Elite Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Elite Pharma Private Limited
Elite Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACE4146L1ZQ | Gujarat | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Elite Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elite Pharma Private Limited
Elite Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 October 1987 (39+ years old) and is registered under CIN U24231GJ1987PTC010062.
Elite Pharma reported revenue of ₹10.71 Cr for FY 2025 (up 3% YoY).
Elite Pharma has 3 current directors:
- Girish Khimji Kantaria - Director
- Jatin Popatlal Patel - Director
- Chintan Hareshbhai Patel - Director
Elite Pharma reported a net profit of ₹1.47 Cr (net margin 13.7%) and EBITDA of ₹2.35 Cr (EBITDA margin 21.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Elite Pharma is 5% over three years and 3% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Elite Pharma is 24AAACE4146L1ZQ, registered in Gujarat.
The CIN (Corporate Identification Number) of Elite Pharma is U24231GJ1987PTC010062. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elite Pharma has 8 court cases on record: 1 filed by the company and 6 filed against it. Most are in the high courts.
Elite Pharma was incorporated on 16 October 1987, making it 39+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Elite Pharma by revenue are Artisan Netcom (India) Private Limited, Triveni Formulations Limited, D M Pharma (MKT.) Private Limited, Oncobiotek Formulations Private Limited, Embellish Pharma Tech Private Limited and 5 more, all in the Pharma industry (Formulations).
Popatlal Harjibhai Patel ceased to be Director on 14 May 2025. Jatin Popatlal Patel was appointed as Director on 04 May 2025. Chintan Hareshbhai Patel was appointed as Director on 28 Apr 2017. Elite Pharma has 6 board changes on record in total.